In cancer, the α-KG/2-HG imbalance caused by IDH mutations triggers malignant epigenetic remodeling by inhibiting TET enzymes; whereas in iPSC reprogramming, exogenous α-KG can mimic embryonic metabolic pulses to enhance efficiency. Here, IDH1 is linked to cancer.